This brand name is authorized in Austria, Australia, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Lithuania, Netherlands, Poland, Singapore, Turkey, United Kingdom, South Africa
The drug BONDRONAT contains one active pharmaceutical ingredient (API):
|
1
Ibandronic acid
UNII J12U072QL0 - IBANDRONATE SODIUM
|
|
Ibandronic acid belongs to the bisphosphonate group of compounds which act specifically on bone. Their selective action on bone tissue is based on the high affinity of bisphosphonates for bone mineral. Bisphosphonates act by inhibiting osteoclast activity, although the precise mechanism is still not clear. In vivo, ibandronic acid prevents experimentally-induced bone destruction caused by cessation of gonadal function, retinoids, tumours or tumour extracts. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| BONDRONAT Film-coated tablets | European Medicines Agency (EU) | MPI, EU: SmPC | |
| BONDRONAT Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M05BA06 | Ibandronic acid | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 5750P, 9357L, 9619G |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00024213, 00283222, 03321176, 03323123, 03422635, 05891475, 05891481, 09384516, 09505227, 09620460, 09686192, 10385567, 10402550, 13916717, 15608776, 16160160, 16804338, 17936852 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 23.815-1-04-11 |
| Country: EE | Ravimiamet | Identifier(s): 1173147, 1173158, 1173169, 1173170, 1173181, 1207987 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 96012009 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61213881, 64530520 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 109260, 75402, 75422 |
| Country: HK | Department of Health Drug Office | Identifier(s): 42670, 52681, 52770, 61449 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1027764, 1027766, 1027767, 1027768, 1027769, 1027770 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 76945 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100125388, 100125402, 100125419 |
| Country: SG | Health Sciences Authority | Identifier(s): 11206P, 13425P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699543091815, 8699543091822, 8699543760032, 8699543760056 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/3.2/0114, A38/3.2/0381, A38/3.2/0562 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
